Startseite Partner Suche Impressum Kontakt Diskussionsforum

-

-

Aktuelle Jobs

-

 

Jobbörse

 

-

Allgemein

-

 

Diskussionsforum

 

 

IFRS/IAS  

 

Newsletter  

Musterabschluss

Abschlüsse

-

Dienstleistungen

-

 

IFRS Anwendergruppe

 

 

Umstellungen auf IFRS  

Software/IFRS-Toolkit

-

Grundlagen

-

 

Was sind IFRS/IAS?

 

 

Was ist der IASB?  

 

Umstellungsprozess  

 

Endorsement  

Glossar

-

Mittelstand

-

 

IFRS für KMU  

-

Literatur

-

 

Presse

 

 

Aufsatzdatenbank  

 

Fachbücher  

Broschüren

-

Texte deutsch

-

 

Framework

 

 

Standards  

Interpretations

-

Texte englisch

-

 

Framework

 

 

Standards  

Interpretations

-

Sonstiges

-

 

Gästebuch

 

 

Archive  

 

Links  

 

Über uns  

Sitemap


-

INTERNATIONAL ACCOUNTING STANDARD 41 (2006)

Previous | Index

  Source

-

Commission Regulation (EC) No 1725/2003 of 29 September 2003 adopting certain international accounting standards in accordance with Regulation (EC)   No 1606/2002 of the European Parliament and of the Council

  Content

-

Additional disclosures for biological assets where fair value cannot be measured reliably

54. If an enterprise measures biological assets at their cost less any accumulated depreciation and any accumulated impairment losses (see paragraph 30) at the end of the period, the enterprise should disclose for such biological assets:

(a) a description of the biological assets;

(b) an explanation of why fair value cannot be measured reliably;

(c) if possible, the range of estimates within which fair value is highly likely to lie;

(d) the depreciation method used;

(e) the useful lives or the depreciation rates used; and

(f) the gross carrying amount and the accumulated depreciation (aggregated with accumulated impairment losses) at the beginning and end of the period.

55. If, during the current period, an enterprise measures biological assets at their cost less any accumulated depreciation and any accumulated impairment losses (see paragraph 30), an enterprise should disclose any gain or loss recognised on disposal of such biological assets and the reconciliation required by paragraph 50 should disclose amounts related to such biological assets separately. In addition, the reconciliation should include the following amounts included in net profit or loss related to those biological assets:

(a) impairment losses;

(b) reversals of impairment losses; and

(c) depreciation.

56. If the fair value of biological assets previously measured at their cost less any accumulated depreciation and any accumulated impairment losses becomes reliably measurable during the current period, an enterprise should disclose for those biological assets:

(a) a description of the biological assets;

(b) an explanation of why fair value has become reliably measurable; and

(c) the effect of the change.

Government grants

57. An enterprise should disclose the following related to agricultural activity covered by this Standard:

(a) the nature and extent of government grants recognised in the financial statements;

(b) unfulfilled conditions and other contingencies attaching to government grants; and

(c) significant decreases expected in the level of government grants.

Effective date and transition

58. This International Accounting Standard becomes operative for annual financial statements covering periods beginning on or after 1 January 2003. Earlier application is encouraged. If an enterprise applies this Standard for periods beginning before 1 January 2003, it should disclose that fact.

59. This Standard does not establish any specific transitional provisions. The adoption of this Standard is accounted for in accordance with IAS 8, net profit or loss for the period, fundamental errors and changes in accounting policies.

 

Previous | Index

 


 

Anzeige

Newsletter:

Name

E-Mail

-

Partner

-

RöverBrönner KG

-

Mediadaten

-

 

Zugriffszahlen

 

Onlinewerbung

-

Veranstalter

-

 

AvenDATA GmbH

 

 

Digitale Signatur

 

 

GDPdU Portal

 

 

Unternehmens-nachfolge

 

 

Verfahrens-dokumentation

 

 

AvenDATA GmbH. Kaiserin-Augusta-Allee 14 . D-10553 Berlin . Deutschland
  Tel +49 30 700 157 500 . Fax +49 30 700 157 599  . E-mail: webmaster@ifrs-portal.com